Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

Alzheimer's-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a ...

A study examining how nanoplastics interact with brain proteins has identified a possible mechanism that could contribute to neurodegenerative diseases.

Within five years, the researchers believe blood tests for early diagnosis of Parkinson’s disease could begin to be tested in healthcare settings. Over the longer term, the findings may also support ...

Summary: Women make up nearly two-thirds of Alzheimer’s patients, and researcher may have just discovered a massive reason why. A new study found that when the protein alpha-synuclein (typically ...

Hearing impairment is a common nonmotor manifestation of Parkinson disease, often involving high-frequency hearing loss.

At age 66, Richard "Dick" Nash first suspected something might be wrong when he participated in a Dallas walk for juvenile ...

Researchers studying Parkinson’s disease have turned to an unlikely source of biological data: human hair. A growing body of peer-reviewed work now shows that stress hormones, trace minerals, and even ...